Document is current

Article History

Received: 28 September 2025

Accepted: 27 January 2026

First Online: 4 February 2026

Declarations

:

: Not applicable

: Not applicable

: This study was performed under the umbrella of the Copenhagen Centre for Regulatory Science (CORS), a cross-faculty university anchored institution involving various public and private stakeholders, as well as patient organisations. The centre is purely devoted to the scientific aspects of the regulatory field and has a patient-oriented focus. The research is not a company-specific product, nor directly company related. C.E.H. is employed by CORS, and L.W. and D.D.G. are PhD candidates at CORS. In the last three years, CORS and C.E.H. have received funding from Novo Nordisk for projects not related to this study. L.W.‘s PhD fellowship is funded by a grant to CORS from Novo Nordisk A/S; however, the company was not involved in any aspect of this work. The funders were not involved in the conception of ideas, study design, data collection methodology, statistical analysis, interpretation of results, manuscript preparation, or the decision to publish. The researchers maintained complete independence throughout all phases of this work, from initial conceptualisation through final dissemination of findings.